This inventor holds 2 USPTO granted patents. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,100 
1 out of 363 
Years Active: 2009-2011
Title: The Innovations of Stanley Belkowski
Introduction
Stanley Belkowski is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of chymase activity. With a total of 2 patents, his work has implications for diagnosing and treating chymase-associated diseases.
Latest Patents
Belkowski's latest patents include a method of determining chymase activity with secretory leukocyte protease inhibitor. This invention reveals that human chymase cleaves human SLPI at a specific site, which can serve as an indicator of chymase activity. The methods provided by this invention allow for the diagnosis of chymase-associated diseases and the evaluation of treatment efficiency in human subjects by measuring SLPI processing.
Career Highlights
Throughout his career, Stanley Belkowski has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in the field.
Collaborations
One of his notable coworkers is Michael R D'Andrea, with whom he has collaborated on various projects.
Conclusion
Stanley Belkowski's innovative work in determining chymase activity has the potential to advance the diagnosis and treatment of related diseases. His contributions to the field are significant and reflect his dedication to biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile